Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04469452 · ClinicalTrials.gov registry record
Validation of a Portable Indirect Calorimeter
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 35
- Enrollment target
NCT04469452: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT04469452 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04469452 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 35 participants
- Enrollment target
Study Summary
This study plans to test the accuracy of a new device (the Apollo EE Device) that measures resting energy expenditure (REE) using only oxygen consumed (VO2). Findings from this study will help determine how this new device compares to the gold standard, indirect calorimetry, which measures REE using VO2 and carbon dioxide production (VCO2). Findings may help develop less expensive and more accessible means of measuring energy expenditure.
Primary Outcome
Measurement of RMR
Interventions
- DEVICE Apollo Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2023-11-28 |
Why NCT04469452 stopped before completion
NCT04469452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Apollo Device is the first listed.
NCT04469452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04469452 about?
NCT04469452 is a clinical study titled "Validation of a Portable Indirect Calorimeter". This study plans to test the accuracy of a new device (the Apollo EE Device) that measures resting energy expenditure (REE) using only oxygen consumed (VO2). Findings from this study will help determine how this new device compares to the gold standard, indirect calorimetry, which measures REE using...
What is the current status of trial NCT04469452?
This trial is currently terminated. The enrollment target is 35 participants. The study started on 2020-09-01. Estimated completion is 2023-11-28.
What interventions are being tested in trial NCT04469452?
The interventions under investigation include: Apollo Device (DEVICE).
Who is sponsoring clinical trial NCT04469452?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI